Periodic Reporting for period 1 - TrickE3 (Chemical rewiring of E3 ubiquitin ligases as a generalizable therapeutic approach)

Despite great progress in therapeutic drug development, ~ 90% of all human proteins remain beyond the reach of conventional drug discovery (inhibitors), leaving some of the most compelling targets inaccessible to therapeutic development. Traditional drug design focuses mainly...